Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing-Reference-Cited by-同舟云学术

Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing

Published:2011-05-07 Issue:1 Volume:132 Page:87-95
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

De Leeneer Kim,Coene Ilse,Crombez Brecht,Simkens Justine,Van den Broecke Rudy,Bols Alain,Stragier Barbara,Vanhoutte Ilse,De Paepe Anne,Poppe Bruce,Claes Kathleen

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-011-1544-9.pdf

Reference40 articles.

1. Miki Y et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66–71

2. Wooster R et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789–792

3. Wooster R et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science 265(5181):2088–2090

4. Kauff ND et al (2002) Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families. J Med Genet 39(8):611–614

5. Gayther SA et al (1997) Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 15(1):103–105

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysis;Familial Cancer;2024-05-19

2. A New de novo BRCA1 Mutation in a Young Breast Cancer Patient: A Case Report;The Application of Clinical Genetics;2023-05

3. BRCA1/2 variants and copy number alterations status in non familial triple negative breast cancer and high grade serous ovarian cancer;Hereditary Cancer in Clinical Practice;2022-08-19

4. Population or family history based BRCA gene tests of breast cancer? A systematic review of economic evaluations;Hereditary Cancer in Clinical Practice;2021-08-28

5. Molecular biomarkers for early detection and prevention of ovarian cancer—A gateway for good prognosis: A narrative review;International Journal of Preventive Medicine;2020